Respiratory Failure

Distinguish Type 1 and Type 2 Respiratory Failure.

Respiratory failure occurs when the lungs cannot effectively exchange gases, leading to insufficient oxygen intake (hypoxemia) and/or inadequate carbon dioxide removal (hypercapnia).

There are Two Types of Respiratory Failure

Type 1 Respiratory Failure:

Hypoxemia with normal or low carbon dioxide levels. This is often caused by V/Q mismatch or shunt.

Type 1 respiratory failure is a failure of oxygenation. Air may be moving in and out of the lungs effectively, but the oxygen is unable to cross into the blood for one reason or another.

Type 1 respiratory failure is characterized by low blood oxygen levels (hypoxemia) with normal or low carbon dioxide levels. This happens when lung tissue is damaged, hindering the lungs’ ability to oxygenate the blood. Some conditions that commonly cause Type 1 respiratory failure are:

pulmonary edema
pneumonia
acute respiratory distress syndrome (ARDS)
idiopathic pulmonary fibrosis (IPF).

In these cases, the damaged lung tissues struggle to effectively transfer oxygen, resulting in low blood oxygen (hypoxemia). However, the remaining healthy parts of the lung can still remove carbon dioxide because less functional lung tissue is needed to eliminate CO₂ than for blood oxygenation.

Type 2 Respiratory Failure:

Hypoxemia with high carbon dioxide levels. This is primarily caused by alveolar hypoventilation.

Type 2 respiratory failure is a failure of ventilation. There is simply not enough air moving in and out of the lungs.

Type 2 respiratory failure involves low blood oxygen and high carbon dioxide levels. It occurs when alveolar ventilation is insufficient to remove the carbon dioxide produced, leading to CO₂ retention. Usually, the underlying cause is reduced alveolar ventilation due to either:

respiratory muscle weakness (“pump failure”)
chest wall deformities
central nervous system depression.

Conditions like Guillain-Barre syndrome exemplify respiratory muscle weakness, while COPD is one of the most common causes of Type 2 respiratory failure overall. In Type 2 respiratory failure, inadequate ventilation stemming from reduced ventilatory effort or an inability to overcome increased resistance to ventilation affects the entire lung. This leads to carbon dioxide buildup in the blood, causing respiratory acidosis and, if untreated, damage to vital organs due to the combination of low oxygen and high carbon dioxide.

A Simple Mnemonic:

Here’s a simple way to remember the difference between the two types:

Type 1 affects one value (PaO2 is low).

Type 2 affects two values (PaO2 is low, and PaCO2 is high).

Management of the Two Types of Respiratory Failure:

Management of Type 1 and Type 2 respiratory failure differs because of the distinct underlying physiological issues.

Management of Type I Respiratory Failure:

Type 1 respiratory failure (hypoxemic respiratory failure): the primary problem is impaired oxygenation, with carbon dioxide levels typically normal or even low (due to compensatory hyperventilation.)

Management, in this case, focuses on improving oxygen levels in the blood. This often involves:

1. Supplemental oxygen administration through various devices, such as nasal cannulae, face masks, or high-flow nasal cannulae, with adjustments made to achieve adequate oxygen saturation without causing oxygen toxicity.

2. Addressing the underlying cause of the hypoxemia. For instance, if pneumonia is the culprit, antibiotics would be administered.

Coming Soon!

The EMR Academy

From CMESurfer

The award-winning team at CME Surfer are working on something special….

The EMR ACADEMY will have you ready to breeze through your EMR program and ace your certification exams with confidence!

Management of Type II Respiratory Failure:

Type 2 respiratory failure (hypercapnic respiratory failure) arises from inadequate ventilation, resulting in both low oxygen and high carbon dioxide levels. Therefore, management in this scenario aims to improve ventilation and reduce carbon dioxide levels. This might involve:

1. Non-invasive ventilation (NIV), such as BiPAP, assists breathing and facilitates carbon dioxide removal.

2. Treatment of the underlying cause, like managing COPD exacerbations with bronchodilators and corticosteroids.

In severe cases or when NIV fails, invasive ventilation (intubation and mechanical ventilation) might be necessary to ensure adequate ventilation and oxygenation.

It’s important to note that Type 1 respiratory failure can progress to Type 2 if left untreated, as the patient becomes exhausted from the effort of hyperventilating.

In such cases, the management approach would need to shift from primarily addressing hypoxemia to also managing hypercapnia.

Resources

Agarwal, R., Gupta, R., Aggarwal, A. N., & Gupta, D. (2008). Noninvasive positive pressure ventilation in acute respiratory failure due to COPD vs other causes: effectiveness and predictors of failure in a respiratory ICU in North India. International Journal of Chronic Obstructive Pulmonary Disease, 3(4), 737–743.

Arthurs, G. J., & Sudhakar, M. (2005). Carbon dioxide transport. Continuing Education in Anaesthesia, Critical Care & Pain, 5(6), 207–210.

Boers, E., Barrett, M., Su, J. G., Benjafield, A. V., Sinha, S., Kaye, L., … & Rice, M. B. (2023). Global burden of chronic obstructive pulmonary disease through 2050. JAMA Network Open, 6(12), e2346598.

Clarke, R. C. N., & Kelly, B. E. (1999). Ventilatory characteristics in mechanically ventilated patients during manual hyperinflation for chest physiotherapy. Anaesthesia, 54(10), 936–940.

Dean, E. (1994). Oxygen transport: a physiologically-based conceptual framework for the practice of cardiopulmonary Physiotherapy. Physiotherapy, 80(6), 347–354.

Fuchs, H., Rossmann, N., Schmid, M. B., Hoenig, M., Thome, U., Mayer, B., … & Kocher, A. (2017). Permissive hypercapnia for severe acute respiratory distress syndrome in immunocompromised children: A single center experience. PLOS One, 12(6), e0179974.

Guglielminotti, J., Alzieu, M., Maury, E., Guidet, B., & Offenstadt, G. (2000). Bedside detection of retained tracheobronchial secretions in patients receiving mechanical ventilation: is it time for tracheal suctioning? Chest, 118(4), 1095–1099.

Hodgson, C. L., Bailey, M., Bellomo, R., Berney, S., Buhr, H., Denehy, L., … & Harrold, M. (2016). A binational multicenter pilot feasibility randomized controlled trial of early goal-directed mobilization in the ICU. Critical Care Medicine, 44(6), 1145–1152.

Hoffman, M., Augusto, V. M., Eduardo, D. S., Silveira, B. M., Lemos, M. D., & Parreira, V. F. (2019). Inspiratory muscle training reduces dyspnea during activities of daily living and improves inspiratory muscle function and quality of life in patients with advanced lung disease. Physiotherapy Theory and Practice, 35(10), 962-971.

Illi, S. K., Held, U., Frank, I., & Spengler, C. M. (2012). Effect of respiratory muscle training on exercise performance in healthy individuals: a systematic review and meta-analysis. Sports Medicine, 42(8), 707–724.

Inal-Ince, D., Savci, S., Topeli, A., & Arikan, H. (2004). Active cycle of breathing techniques in non-invasive ventilation for acute hypercapnic respiratory failure. Australian Journal of Physiotherapy, 50(2), 67–73.

Jolliet, P., Bulpa, P., & Chevrolet, J. C. (1998). Effects of the prone position on gas exchange and hemodynamics in severe acute respiratory distress syndrome. Critical Care Medicine, 26(12), 1977–1985.

Kayambu, G., Boots, R., & Paratz, J. (2015). Early physical rehabilitation in intensive care patients with sepsis syndromes: a pilot randomised controlled trial. Intensive Care Medicine, 41(1), 865–874.

Mackenzie, I. (Ed.). (2008). Core topics in mechanical ventilation. Cambridge University Press.

Mirabile, V. S., Shebl, E., Sankari, A., & Burns, B. (2023). Respiratory Failure in Adults. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK526127/

Mure, M., Martling, C. R., & Lindahl, S. G. (1997). Dramatic effect on oxygenation in patients with severe acute lung insufficiency treated in prone position. Critical Care Medicine, 25(9), 1539–1544.

Noveanu, M., Breidthardt, T., Reichlin, H., Gayat, E., Potocki, M., Pragger, H., … & Mueller, C. (2010). Effect of oral beta-blocker on short term and long term mortality in patients with acute respiratory failure: results from the BASEL-II-ICU study. Critical Care, 14(6), R198. https://doi.org/10.1186/cc9317

Phua, J., Badia, J. R., & Adhikari, N. K. J. (2009). Has mortality from acute respiratory distress syndrome decreased over time? A systematic review. American Journal of Respiratory and Critical Care Medicine, 179(3), 220–227.

Schaller, S. J., Anstey, M., Blobner, M., Edrich, T., Grabitz, S. D., Gradwohl-Matis, I., … & Meybohm, P. (2016). Early, goal-directed mobilisation in the surgical intensive care unit: a randomised controlled trial. The Lancet, 388(10052), 1377–1388.

Shebl, E., & Burns, B. (2018). Respiratory failure. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK526127/